Immunomodulation and matrix metalloproteinases in viral myocarditis (Q37591573)

21 August 2017

1 reference

title

Immunomodulation and matrix metalloproteinases in viral myocarditis (English)

1 reference

21 August 2017

Carsten Tschöpe

1 reference

21 August 2017

Dirk Westermann

1 reference

21 August 2017

Heinz-Peter Schultheiss

series ordinal

object named as

Heinz-Peter Schultheiss

1 reference

21 August 2017

author name string

Konstantinos Savvatis

series ordinal

1 reference

21 August 2017

publication date

1 September 2009

1 reference

Journal of Molecular and Cellular Cardiology

21 August 2017

published in

1 reference

21 August 2017

1 reference

21 August 2017

1 reference

21 August 2017

page(s)

468-473

1 reference

The role of B lymphocytes in coxsackievirus B3 infection

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.08.019

The suppressor of cytokine signaling-1 (SOCS1) is a novel therapeutic target for enterovirus-induced cardiac injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.08.019

Matrix metalloproteinases and the regulation of tissue remodelling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.08.019

Structure and function of matrix metalloproteinases and TIMPs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.08.019

TNF-alpha suppresses alpha-smooth muscle actin expression in human dermal fibroblasts: an implication for abnormal wound healing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.08.019

Signal transduction and cell-type specific regulation of matrix metalloproteinase gene expression: can MMPs be good for you?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.08.019

The regulation of matrix metalloproteinases and their inhibitors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.08.019

Inflammation and cardiac remodeling during viral myocarditis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.08.019

How matrix metalloproteinases regulate cell behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.08.019

Extracellular matrix remodelling and cellular differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.08.019

Intracellular targets of matrix metalloproteinase-2 in cardiac disease: rationale and therapeutic approaches

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.08.019

Matrix metalloproteinase-9-mediated dendritic cell recruitment into the airways is a critical step in a mouse model of asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.08.019

Matrix metalloproteinases and tissue inhibitors of metalloproteinases in coxsackievirus-induced myocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.08.019

Persistent expression of cytokines in the chronic stage of CVB3-induced myocarditis in NMRI mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.08.019

Reduction in myocardial collagen cross-linking parallels left ventricular dilatation in rat models of systolic chamber dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.08.019

Endothelial extracellular matrix: biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.08.019

A Matrix Metalloproteinase Induction/Activation System Exists in the Human Left Ventricular Myocardium and Is Upregulated in Heart Failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.08.019

Degradation of myosin light chain in isolated rat hearts subjected to ischemia-reperfusion injury: a new intracellular target for matrix metalloproteinase-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.08.019

Strategies for MMP inhibition in cancer: innovations for the post-trial era.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.08.019

Matrix metalloproteinases as modulators of inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.08.019

Overlapping and independent contributions of MMP2 and MMP9 to lung allergic inflammatory cell egression through decreased CC chemokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.08.019

Cell-surface association between matrix metalloproteinases and integrins: role of the complexes in leukocyte migration and cancer progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.08.019

Degradation of interleukin 1beta by matrix metalloproteinases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.08.019

Matrix metalloproteinase-7-dependent release of tumor necrosis factor-alpha in a model of herniated disc resorption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.08.019

Gelatinase B/matrix metalloproteinase-9 cleaves interferon-beta and is a target for immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.08.019

Proteomics discovery of metalloproteinase substrates in the cellular context by iTRAQ labeling reveals a diverse MMP-2 substrate degradome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.08.019

Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.08.019

Gelatinase B/MMP-9 and neutrophil collagenase/MMP-8 process the chemokines human GCP-2/CXCL6, ENA-78/CXCL5 and mouse GCP-2/LIX and modulate their physiological activities.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.08.019

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.08.019

The first stage of transforming growth factor beta1 activation is release of the large latent complex from the extracellular matrix of growth plate chondrocytes by matrix vesicle stromelysin-1 (MMP-3)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.08.019

Cleavage of syndecan-1 by membrane type matrix metalloproteinase-1 stimulates cell migration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.08.019

Osteopontin, a novel substrate for matrix metalloproteinase-3 (stromelysin-1) and matrix metalloproteinase-7 (matrilysin).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.08.019

Matrilysin (matrix metalloproteinase-7) mediates E-cadherin ectodomain shedding in injured lung epithelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.08.019

Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.08.019

Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.08.019

CXCL10 inhibits viral replication through recruitment of natural killer cells in coxsackievirus B3-induced myocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.08.019

Inhibition of urokinase-type plasminogen activator or matrix metalloproteinases prevents cardiac injury and dysfunction during viral myocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.08.019

Amelioration of coxsackievirus B3-mediated myocarditis by inhibition of tissue inhibitors of matrix metalloproteinase-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.08.019

Structure, function and antagonists of urokinase-type plasminogen activator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.08.019

Ablation of matrix metalloproteinase-9 increases severity of viral myocarditis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.08.019

Acute actions and novel targets of matrix metalloproteinases in the heart and vasculature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.08.019

10.1016/J.YJMCC.2009.08.019

7 January 2021

Identifiers

DOI

1 reference

21 August 2017

1 reference